Philippine Pharmas Could See Extra R&D Funds From Proposed Bill
This article was originally published in PharmAsia News
Executive SummaryPhilippine drug makers stand to gain from a government proposal to add substantial funds to the nation's $2.3 million drug-research coffers
You may also be interested in...
The Trump administration does not believe its partnership with industry on therapeutics for COVID-19 should include conditions on pricing, US Health Secretary Alex Azar tells Congress.